Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects
about
Elevation and persistence of CD8 T-cells in HIV infection: the Achilles heel in the ART eraTrial Watch: Immunogenic cell death inducers for anticancer chemotherapyCardiac glycosides use and the risk of lung cancer: a nested case-control studyMolecular mechanisms of ATP secretion during immunogenic cell deathRGS expression in cancer: oncomining the cancer microarray data.Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity SetDigitalis use and risk of gastrointestinal cancers: A nationwide population-based cohort study.Cardiac glycosides display selective efficacy for STK11 mutant lung cancer.Targeting FXYD2 by cardiac glycosides potently blocks tumor growth in ovarian clear cell carcinoma.HIF inhibitors for ischemic retinopathies and cancers: options beyond anti-VEGF therapies.Targeting the hallmarks of cancer with therapy-induced endoplasmic reticulum (ER) stress.Dendritic cells as gatekeepers of tolerance.Using computational strategies to predict potential drugs for nasopharyngeal carcinoma.Digitalis Use and the Risk of Breast Cancer: A Systematic Review and Meta-Analysis.Cytokines in immunogenic cell death: Applications for cancer immunotherapy.Use of cardiac glycosides and risk of glioma.Cardiac glycosides suppress the maintenance of stemness and malignancy via inhibiting HIF-1α in human glioma stem cells.Computational Cell Cycle Profiling of Cancer Cells for Prioritizing FDA-Approved Drugs with Repurposing Potential.Immune effectors required for the therapeutic activity of vorinostat.Immunosuppressants in cancer prevention and therapyConsensus guidelines for the detection of immunogenic cell death.Trial Watch: Lenalidomide-based immunochemotherapy.Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.Cardiac glycosides and the risk of breast cancer in women with chronic heart failure and supraventricular arrhythmia.Epigenetic Modulation of CD8⁺ T Cell Function in Lentivirus Infections: A Review.Trial watch: Chemotherapy with immunogenic cell death inducers.Is digoxin a breast cancer risk factor?
P2860
Q26768147-8B676871-3DF0-4D51-B1E8-A67B6E2DCF1EQ27004011-BF77C802-F6EA-4ACF-83A2-0380D19A9108Q28392316-4D745D53-1C9F-4CE7-9EAC-FA415547D029Q30408773-BE294068-D8E6-4C8B-8A7C-6B512332695DQ30596824-FB616A7C-05BD-42FB-B9BA-14C4FB3BE3ABQ33776379-EC60FB40-FE4C-4D3F-8B00-39C8BCE56DB6Q33798566-1F9A535A-6971-4C82-8CFD-AFE060AF6F65Q37105125-7C348628-B3DA-485C-932B-5853E4F5D8B7Q37665204-8E6138F4-B1C2-4CF0-AAD2-00588C2BFD73Q38825960-6E216417-BEC8-4BF3-A018-A0711E138BD8Q38866745-CBC98C3A-B899-490F-9718-D472F4E862FCQ38908238-E0E76F4F-5E43-4BE6-A70F-654B0573F6DEQ39095740-09ECBC4A-DCA4-4C94-8C78-3697D1C93706Q39107268-00B5DC9E-F694-49E4-9BE9-69568FA260BFQ39397491-C4215BA9-38F8-408F-BEBE-0C3F65B1620EQ40154465-1352CAA4-7EDF-4390-9D3A-1BE723DD39BEQ41092445-AD097308-D817-4066-946F-08E510D175E2Q41195283-C6E16634-805C-4B53-B53F-8368D50075E5Q41871572-5023C7EB-2EF3-4876-8E45-CA7981F70866Q42505783-7EE20454-1ED3-45AD-AFF6-FCA73B85A9F7Q42553556-732990E6-9AE5-4C51-8734-86125F4C5683Q42737828-11901BF3-6862-4E5B-A7F8-BC29D1DC13D2Q50005505-19CAB501-C712-4809-A12B-0EB498D85CF7Q53149725-E7625119-E8EE-4EAB-8E1C-6F3C810B1018Q54942553-31324DA1-7E50-4890-B1D5-4E4E750FD3FDQ55658029-61822BF0-21BE-4527-80DB-8FB2EA139286Q58181734-12BCEE6E-8725-489E-8DD3-80B393015A4C
P2860
Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Anticancer activity of cardiac ...... mous and immunological effects
@ast
Anticancer activity of cardiac ...... mous and immunological effects
@en
type
label
Anticancer activity of cardiac ...... mous and immunological effects
@ast
Anticancer activity of cardiac ...... mous and immunological effects
@en
prefLabel
Anticancer activity of cardiac ...... mous and immunological effects
@ast
Anticancer activity of cardiac ...... mous and immunological effects
@en
P2860
P50
P356
P1433
P1476
Anticancer activity of cardiac ...... mous and immunological effects
@en
P2093
Abdul Qader Sukkurwala
P2860
P304
P356
10.4161/ONCI.21684
P50
P577
2012-12-01T00:00:00Z